OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting the oncogenic m6A demethylase FTO suppresses tumourigenesis and potentiates immune response in hepatocellular carcinoma
Ao Chen, Xin Zhang, Qingyang Zhang, et al.
Gut (2024) Vol. 74, Iss. 1, pp. 90-102
Open Access | Times Cited: 17
Ao Chen, Xin Zhang, Qingyang Zhang, et al.
Gut (2024) Vol. 74, Iss. 1, pp. 90-102
Open Access | Times Cited: 17
Showing 17 citing articles:
ALKBH5 acts a tumor-suppressive biomarker and is associated with immunotherapy response in hepatocellular carcinoma
Hehua Ma, Yuxin Hong, Zhenzhen Xu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Hehua Ma, Yuxin Hong, Zhenzhen Xu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
New insights into N6-methyladenosine in hepatocellular carcinoma immunotherapy
Mengran Li, Hu Tian, Y Zhuang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Mengran Li, Hu Tian, Y Zhuang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
MSC-sEVs exacerbate senescence by transferring bisecting GlcNAcylated GPNMB
Yuanye Ma, Chen Zhao, Jingjing Feng, et al.
Stem Cell Research & Therapy (2025) Vol. 16, Iss. 1
Open Access
Yuanye Ma, Chen Zhao, Jingjing Feng, et al.
Stem Cell Research & Therapy (2025) Vol. 16, Iss. 1
Open Access
Nitidine chloride inhibits the progression of hepatocellular carcinoma by suppressing IGF2BP3 and modulates metabolic pathways in an m6A-dependent manner
Dandan Xiong, Zhen-dong Chen, Jian-di Li, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access
Dandan Xiong, Zhen-dong Chen, Jian-di Li, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access
The role of FTO in m6A RNA methylation and immune regulation in Staphylococcus aureus infection-related osteomyelitis
Sijing Liu, Kai Li, Changhai Long, et al.
Frontiers in Microbiology (2025) Vol. 16
Open Access
Sijing Liu, Kai Li, Changhai Long, et al.
Frontiers in Microbiology (2025) Vol. 16
Open Access
Tumor Metastasis: Mechanistic Insights and Therapeutic Intervention
Lin Tang, Peng Shen, Xiaoying Zhuang, et al.
MedComm – Oncology (2025) Vol. 4, Iss. 1
Open Access
Lin Tang, Peng Shen, Xiaoying Zhuang, et al.
MedComm – Oncology (2025) Vol. 4, Iss. 1
Open Access
m6A epitranscriptomic modification in hepatocellular carcinoma: implications for the tumor microenvironment and immunotherapy
Yong Li, Qingbin Liu, Xianying Li, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Yong Li, Qingbin Liu, Xianying Li, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
The m6A revolution: transforming tumor immunity and enhancing immunotherapy outcomes
Tongguo Shi, Huan Zhang, Yueqiu Chen
Cell & Bioscience (2025) Vol. 15, Iss. 1
Open Access
Tongguo Shi, Huan Zhang, Yueqiu Chen
Cell & Bioscience (2025) Vol. 15, Iss. 1
Open Access
Development of 3-Arylaminothiophenic-2-carboxylic Acid Derivatives as New FTO Inhibitors Showing Potent Antileukemia Activities
Deyan Zhang, Lu Liu, Ming Li, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117444-117444
Closed Access
Deyan Zhang, Lu Liu, Ming Li, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117444-117444
Closed Access
A patenting perspective of fat mass and obesity associated protein (FTO) inhibitors: 2017-present
Ze Dong, Yue Huang, Wenyang Xia, et al.
Expert Opinion on Therapeutic Patents (2025)
Closed Access
Ze Dong, Yue Huang, Wenyang Xia, et al.
Expert Opinion on Therapeutic Patents (2025)
Closed Access
FTO/m6A/GPNMB axis: a novel promising target for hepatocellular carcinoma (HCC) treatment?
Bernd Heinrich, Francisco Javier Cubero
Gut (2024) Vol. 74, Iss. 1, pp. 5-6
Closed Access | Times Cited: 1
Bernd Heinrich, Francisco Javier Cubero
Gut (2024) Vol. 74, Iss. 1, pp. 5-6
Closed Access | Times Cited: 1
N6-methyladenosine regulators in hepatocellular carcinoma: investigating the precise definition and clinical applications of biomarkers
Xiaokai Yan, Yao Qi, Xinyue Yao, et al.
Biology Direct (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 1
Xiaokai Yan, Yao Qi, Xinyue Yao, et al.
Biology Direct (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 1
YTHDF2 promotes anaplastic thyroid cancer progression by activating the DDIT4/AKT/mTOR signaling pathway
Bao Dai, Lei Xu, Shikuo Rong, et al.
Biology Direct (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 1
Bao Dai, Lei Xu, Shikuo Rong, et al.
Biology Direct (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 1
METTL3-mediated SMPDL3A promotes cell growth, metastasis and immune process of hepatocellular carcinoma by regulating LRPPRC
Wei-Xin Xu, Miaomiao Tao, Yeqiong Liu, et al.
Cellular Signalling (2024), pp. 111543-111543
Closed Access | Times Cited: 1
Wei-Xin Xu, Miaomiao Tao, Yeqiong Liu, et al.
Cellular Signalling (2024), pp. 111543-111543
Closed Access | Times Cited: 1
RNA modifications in cancer immune therapy: regulators of immune cells and immune checkpoints
Xiangyu Qin, Huali Liu, Qixuan Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Xiangyu Qin, Huali Liu, Qixuan Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
RNA modification in normal hematopoiesis and hematologic malignancies
Xi Chen, Yixiao Yuan, Fan Zhou, et al.
MedComm (2024) Vol. 5, Iss. 11
Open Access
Xi Chen, Yixiao Yuan, Fan Zhou, et al.
MedComm (2024) Vol. 5, Iss. 11
Open Access
Emerging roles of N6-methyladenosine in arsenic-induced toxicity
Rui Li, Cuixia Wu, Yu‐Wan Zhao, et al.
Heliyon (2024) Vol. 10, Iss. 22, pp. e40473-e40473
Open Access
Rui Li, Cuixia Wu, Yu‐Wan Zhao, et al.
Heliyon (2024) Vol. 10, Iss. 22, pp. e40473-e40473
Open Access
m6A and beyond: RNA modifications shaping angiogenesis
Yu Luan, Renbing Jia, Peiwei Chai, et al.
Trends in Molecular Medicine (2024)
Closed Access
Yu Luan, Renbing Jia, Peiwei Chai, et al.
Trends in Molecular Medicine (2024)
Closed Access
